CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
基本信息
- 批准号:7471675
- 负责人:
- 金额:$ 28.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxybutanalAcetatesAcetoneAcidityAcidsAgeAlcoholsAldehydesAlder plantAlkenesAllyAmidesAminesAreaAromatic AminesAziridinesBenzodiazepinesBiologicalBiological FactorsBooksBromidesCD3 AntigensCarbonCarbonatesCatalysisCharacteristicsChemicalsChemistryChromiumCobaltCollaborationsCommunity Health Nurse SpecialistCompatibleComplexConditionCopperCoupledCrystallizationCyclizationCyclopropanesDNA Sequence RearrangementDataDetectionDevelopmentDiels Alder reactionDiscriminationDissociationDoctor of PhilosophyElectron TransportElectronicsEmployee StrikesEpoxy CompoundsEquilibriumEstersEthersEthyl EtherExclusionFacility Construction Funding CategoryFree EnergyFundingGoalsGrantHalogensHeterocyclic CompoundsHigh Pressure Liquid ChromatographyHydrogenHydrogen PeroxideHydrolysisHydroxide IonHydroxidesIminesIndividualInvestigationIonsIsomerismIsoquinolinesIsotopesKetonesKineticsLaboratoriesLactonesLeadLigandsLinkManganeseManuscriptsMediatingMetalsMethodologyMethodsModelingModificationNitrogenNumbersObject AttachmentOrganic SynthesisOutcomeOxygenPalladiumPathway interactionsPhenolsPhysical condensationPolymersPositioning AttributePotassiumPreparationPrincipal InvestigatorProcessProlinePublicationsPublishingPyrazolesPyrrolesPyrrolidinesQuinineRangeRateReactionRecoveryRefluxRelative (related person)ReportingResearchResearch Peer ReviewResortRhodiumRoleRouteRutheniumScandiumSchemeSiteSolubilitySolventsStandards of Weights and MeasuresSteroidsSulfonamidesSystemTechniquesTemperatureThermodynamicsTitaniumTolueneTransfer RNAUnited States National Institutes of HealthUnsaturated Fatty AcidsVariantVertebral columnWateralkyl groupanalogazetidinoneaziridinebasecarbenecarbonyl compoundcarboxylatecatalystcopingcycloadditioncyclopropanedecanedeprotonationdesigndesirediazo compounddirhodium tetraacetatedirhodium tetrakis(S-(N-dodecylbenzenesulfonyl)prolinate)enolhydronium ioninhibitor/antagonistinsightinterestnoveloxidationperoxidationpreventprogramspyrazolepyridinepyrrolidinepyrrolineracemizationsizesodium ionstereochemistrytert-Butylhydroperoxidetertiary aminetetrahydrofuranylide
项目摘要
The goal of this research program is the design and development of highly selective and efficient catalytic
processes for the synthesis of biologically relevant compounds. Investigations will build upon our newest
discoveries with unique catalytic uses of dirhodium carboxamidates. Breakthroughs in their applications for
chemical oxidations and as chiral Lewis acids have demonstrated greatly enhanced versatility for these
catalysts that will be further explored. The fixed stereodefined geometry of these catalysts provides access
to highly enantioenriched products in metal carbene reactions of diazoacetates and, together with their low
oxidation potentials, also provides capabilities for highly selective Lewis acid catalyzed reactions and
efficient chemical oxidations. In all aims we seek high turnover numbers and high selectivities. In this
funding period we will resolve limitations of chiral dirhodium carboxamidates for metal carbene transform-
ations by novel processes for which preliminary results indicate that the aims will be achieved. We will
develop diazo chemistry for catalytic stereoselective transformations to further enhance applicability of
catalytic metal carbene chemistry in organic synthesis. New catalytic syntheses of multi-functional ¿-keto-a-
diazoesters with subsequent catalytic metal carbene transformations provides highly efficient access to more
complex carbon frameworks than previously possible through reactions with diazoacetates. We will use
active Lewis acidic chiral dirhodium(ll,lll) carboxamidate catalysts to broaden the range of applicable carbon-
carbon bond forming transformations. Reactivity and selectivity enhancement through chiral dirhodium(ll,lll)
catalysts expands their utilization to Lewis acid catalyzed reactions for which chiral dirhodium(ll,ll) catalysts
are ineffective, and initial focus will be given to those transformations for which preliminary results are most
promising. We will develop and apply catalytic oxidative methodologies to compounds that are of biological
significance. Newly discovered tert-butyl hydroperoxide oxidations catalyzed by dirhodium caprolactamate,
based largely on its low oxidation potential and solubilities, offer a unique opportunity to develop a spectrum
of oxidative transformations, compatible with water as a solvent, that are not easily achieved by other
methods (especially allylic and benzylic oxidations). Applications encompass reactions with steroids,
phenolic compounds, unsaturated fatty acids, amines, and other biologically relevant substrates.
该研究计划的目标是设计和开发高选择性和高效的催化剂,
生物学相关化合物的合成方法。调查将建立在我们最新的
发现了氨甲酰二铑的独特催化用途。在其应用程序中的突破,
化学氧化和作为手性刘易斯酸已经证明了这些化合物的极大增强的通用性。
催化剂将进一步探索。这些催化剂的固定的立体限定的几何形状提供了进入
重氮乙酸盐的金属卡宾反应中的高度对映体富集的产物,以及它们的低
氧化电位,还提供了高选择性刘易斯酸催化反应的能力,
有效的化学氧化。在所有目标中,我们寻求高流动性和高选择性。在这
在资助期内,我们将解决手性二铑羧酰胺化物用于金属卡宾转化的局限性-
通过新的方法,其初步结果表明目标将实现。我们将
开发用于催化立体选择性转化的重氮化学,以进一步增强
有机合成中的催化金属卡宾化学。多功能戊酮-α-酮的催化合成新方法
重氮酯与随后的催化金属卡宾转化提供了高效的获得更多
通过与重氮乙酸酯的反应,比以前可能的更复杂的碳框架。我们将使用
活性刘易斯酸性手性二铑(II,III)甲酰胺化物催化剂,以拓宽可应用的碳-
碳键形成转变。手性铑(II,III)催化剂的反应性和选择性提高
催化剂将它们的应用扩展到刘易斯酸催化的反应,对于该反应,手性铑(II,II)催化剂
是无效的,最初的重点将放在那些初步成果最重要的转型上。
很有希望我们将开发和应用催化氧化方法学的化合物,是生物
意义新发现的己内酰胺二铑催化的叔丁基过氧化氢氧化反应,
主要基于其低氧化电位和溶解度,提供了一个独特的机会,
氧化转化,与水作为溶剂相容,这是不容易实现的其他
方法(特别是烯丙基和苄基氧化)。应用包括与类固醇的反应,
酚类化合物、不饱和脂肪酸、胺和其它生物学相关底物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael PATRICK Doyle其他文献
Michael PATRICK Doyle的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael PATRICK Doyle', 18)}}的其他基金
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
2183998 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
2770975 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6525641 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
3305946 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6179371 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6606586 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
6795903 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
7928258 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
CHIRAL CATALYSTS FOR ENANTIOSELECTIVE SYNTHESES
用于对映选择性合成的手性催化剂
- 批准号:
7498720 - 财政年份:1991
- 资助金额:
$ 28.44万 - 项目类别:
相似海外基金
Development of palladium-catalyzed novel organic transformations of silylated allyl acetates
钯催化的硅烷化乙酸烯丙酯新型有机转化的开发
- 批准号:
18K05101 - 财政年份:2018
- 资助金额:
$ 28.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Biosynthesis of Methylketones and 2-Alkany l Acetates
甲基酮和 2-烷酰基乙酸酯的生物合成
- 批准号:
9118188 - 财政年份:1992
- 资助金额:
$ 28.44万 - 项目类别:
Standard Grant














{{item.name}}会员




